Scarica l'app Stockscreener
17.73
1.53%
-0.275
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché AVTX Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$18.00
Aprire:
$17.82
Volume 24 ore:
100.14K
Relative Volume:
0.26
Capitalizzazione di mercato:
$320.79M
Reddito:
$1.93M
Utile/perdita netta:
$-7.96M
Rapporto P/E:
-0.00502
EPS:
-3530.8178
Flusso di cassa netto:
$-36.78M
1 W Prestazione:
-6.68%
1M Prestazione:
+7.78%
6M Prestazione:
+309.47%
1 anno Prestazione:
+77.66%
Intervallo 1D:
$17.21
$18.03
Intervallo di 1 settimana:
$15.53
$18.80
Portata 52W:
$3.39
$19.41
Avalo Therapeutics Inc Stock (AVTX) Company Profile
Nome
Avalo Therapeutics Inc
Settore
Industria
Telefono
410-522-8707
Indirizzo
1500 LIBERTY RIDGE DRIVE, WAYNE
Confronta AVTX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AVTX
Avalo Therapeutics Inc
|
17.69 | 325.50M | 1.93M | -7.96M | -36.78M | -3,530.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.42 | 116.04B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
720.75 | 75.97B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
459.78 | 61.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
903.07 | 56.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.03 | 43.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Avalo Therapeutics Inc Stock (AVTX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-17 | Reiterato | H.C. Wainwright | Buy |
| 2025-09-05 | Iniziato | TD Cowen | Buy |
| 2025-08-15 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-06-02 | Ripresa | H.C. Wainwright | Buy |
| 2025-03-25 | Iniziato | Jefferies | Buy |
| 2025-03-25 | Iniziato | Stifel | Buy |
| 2025-02-28 | Iniziato | Piper Sandler | Overweight |
| 2025-02-21 | Iniziato | Wedbush | Outperform |
| 2024-12-19 | Iniziato | BTIG Research | Buy |
| 2024-10-24 | Iniziato | H.C. Wainwright | Neutral |
| 2024-04-16 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2021-09-24 | Iniziato | RBC Capital Mkts | Outperform |
Mostra tutto
Avalo Therapeutics Inc Borsa (AVTX) Ultime notizie
Why analysts maintain buy rating on Avalo Therapeutics Inc. (C6K0) stockWeekly Risk Report & Reliable Intraday Trade Alerts - Newser
Why Avalo Therapeutics Inc. (C6K0) stock could be next leaderGlobal Markets & Expert Curated Trade Setup Alerts - Newser
Why Avalo Therapeutics Inc. (C6K0) stock stays resilient2025 Support & Resistance & Risk Managed Investment Strategies - Newser
How buybacks impact Avalo Therapeutics Inc. stock value2025 Winners & Losers & Low Risk Investment Opportunities - Newser
What hedge fund activity signals for Avalo Therapeutics Inc. stockDip Buying & Low Drawdown Trading Techniques - Newser
Financial Comparison: InMed Pharmaceuticals (NASDAQ:INM) & Avalo Therapeutics (NASDAQ:AVTX) - Defense World
Is Avalo Therapeutics Inc. (C6K0) stock a top dividend aristocrat candidateNew Guidance & Safe Entry Momentum Tips - Newser
Published on: 2025-12-03 02:49:42 - Newser
Is Avalo Therapeutics Inc. (C6K0) stock overpriced at current multiplesWeekly Market Summary & Low Drawdown Investment Ideas - Newser
Avalo Therapeutics, Inc. (NASDAQ:AVTX) Receives $31.67 Average PT from Analysts - Defense World
Taking the lead: Avalo Therapeutics Inc (AVTX) - Setenews
How Avalo Therapeutics Inc. stock benefits from strong dollarTrade Exit Summary & AI Based Buy and Sell Signals - Newser
Avalo Therapeutics, Inc. Updates Investor Presentation - TradingView
Is Avalo Therapeutics Inc. (C6K0) stock resilient in recession scenariosWeekly Risk Summary & Smart Allocation Stock Reports - Newser
What is the fair value of Avalo Therapeutics Inc. stock nowInflation Watch & Risk Controlled Stock Pick Alerts - Newser
How Avalo Therapeutics Inc. (C6K0) stock performs in easing cyclesGap Up & Community Consensus Trade Alerts - Newser
Avalo Therapeutics, Inc. (NASDAQ:AVTX) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Avalo Therapeutics Reports Q3 2025 Financial Results - MSN
HC Wainwright Has Bearish Estimate for AVTX FY2025 Earnings - Defense World
Research Analysts Set Expectations for AVTX FY2025 Earnings - MarketBeat
How Avalo Therapeutics Inc. (C6K0) stock stacks up against competitorsJuly 2025 Spike Watch & Risk Controlled Daily Trade Plans - newser.com
What valuation ratios show for Avalo Therapeutics Inc. (C6K0) stockRate Hike & Fast Momentum Stock Entry Tips - newser.com
How Avalo Therapeutics Inc. (C6K0) stock valuation compares with sectorMarket Activity Recap & Weekly Momentum Picks - newser.com
Is Avalo Therapeutics Inc. stock supported by strong cash flowsMarket Performance Recap & Smart Swing Trading Alerts - newser.com
Has Avalo Therapeutics Inc. formed a bullish divergenceJuly 2025 Sentiment & Accurate Technical Buy Alerts - newser.com
D pipelineJuly 2025 Market Mood & Technical Pattern Recognition Alerts - newser.com
Avalo Therapeutics, Inc. (AVTX) -3.17% in Pre-market: Stock Slides Amid Recent Developments - Stocks Telegraph
Can Avalo Therapeutics Inc. (C6K0) stock test all time highsChart Signals & Comprehensive Market Scan Reports - newser.com
Avalo Therapeutics Inc Azioni (AVTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Avalo Therapeutics Inc Azioni (AVTX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Goldman Jonathan | Director |
Nov 14 '25 |
Sale |
14.33 |
11,367 |
162,937 |
0 |
0.72%
0.83%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):